The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 31% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it none, with a mean price target of $74.
Frontdoor, Inc.
FTDR · Nasdaq · USD · Market cap $6.4B · 2,034 employees
Frontdoor, Inc.
FAIL · Does not pass the screenPrice as of 18 Nov 2026Daily close, not a live quote
Screened 2026-11-18 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price93.59 USD at the 18 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 18 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.24)
- Last reviewed18 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $85.27 to $142.11, base estimate $106.85 (screen dated 2026-11-18).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.24, read 2026-11-14
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Frontdoor, Inc. holds its Markup at $93.59. Consolidating, no directional conviction, held for 50 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 50 days |
| Price at the screen | $93.59 |
| Valuation | 23.73 trailing · 18.41 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.60 |
Five Screens: FTDR's Results
FAIL. Debt ratio
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 55.60% | Below 33% | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 26.89% | Below 49% | Pass |
| Revenue purity | 1.05% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
Frontdoor,'s business is in a permissible area, but its interest-bearing debt is about 56% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when FTDR's ethical verdict changes
Today FTDR does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 18 Nov 2026: it trades at roughly a 12% discount to our $106.85 fair value, 6.00% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-18 screen. The gold marker is the market price at the same screen. A 12.4% discount to the base estimate.
Third-party analyst targets: 5 covering, consensus Buy. The average target sits +7% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $106.85, with a range of $85.27 to $142.11, dated to the 2026-11-18 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsHome warranties look defensive until housing slows
Picture a family watching their boiler fail mid-winter. Frontdoor steps in with a policy that covers the repair bill. The numbers show a 121% return on equity and a clean pass on the ethical screen, yet revenue advances only 6% a year and the shares sit just 8% below our fair value.
Why we pass. A 15 times forward earnings multiple is hardly cheap for modest growth and unknown competitive protection. Median analyst targets rest at $76, almost exactly where the stock trades today.
Risk sits in the housing cycle and discretionary consumer spending. Any dip in home sales or repair activity can cut volumes quickly even when reported returns look strong. Analysis, not advice.
| Forward P/E | 18.4xexpensive even after accounting for its growth |
| Trailing P/E | 23.7xa premium valuation |
| EPS, trailing | 4.01 |
| EPS, forward | 5.17 |
| Revenue growth | +6.0%slow but positive growth |
| Profit margin | 13.0%thin but positive margins |
| Return on equity | 90.3%an exceptional return on shareholder capital |
| FCF yield | 5.17% |
| Debt to equity | 3.72heavy leverage: higher risk if revenue softens |
| Current ratio | 1.75healthy short-term liquidity |
| Beta | 1.60much more volatile than the market |
| Short interest, float | 0.07% |
| 52-week range | 48.90 - 103.07 |
| Market cap | $6.4B |
| Employees | 2,034 |
FTDR-specific watchpoints · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it none, with a mean price target of $74.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 18%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (5 analysts) rates it none, with a mean price target of $74. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Frontdoor: 3 Key Takeaways for Long-Term Investors Yahoo Finance · 10d ago
- Frontdoor (FTDR) Stock May Be 44% Undervalued After $1B Buyback Plan Yahoo Finance · 13d ago
- These Stocks Power Through Rough Week For Stock Market, Trade In Buy Zones Yahoo Finance · 14d ago
- Frontdoor, Inc. Q3 2026 Earnings Call Summary Yahoo Finance · 14d ago
- Frontdoor Inc (FTDR) (Q3 2026) Earnings Call Highlights: Revenue Climbs 6% to $655 Million as ... Yahoo Finance · 14d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $63.78 | +5.0% | · | $1,050 | +5.0% |
| 2 months | $56.73 | +18.1% | · | $1,181 | +18.1% |
| 3 months | $63.18 | +6.0% | · | $1,060 | +6.0% |
| 6 months | $54.87 | +22.1% | · | $1,221 | +22.1% |
| 1 year | $56.73 | +18.1% | · | $1,181 | +18.1% |
| 2 years | $34.97 | +91.5% | · | $1,915 | +91.5% |
| 3 years | $31.84 | +110.4% | · | $2,104 | +110.4% |
| 5 years | $51.83 | +29.2% | · | $1,292 | +29.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FTDR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.